Ascendiant Capital Reiterates Rating on SNYR $SNYR
Key Points
- Ascendiant Capital now rates Synergy CHC Corp. ($SNYR) "buy" with a $3.75 target.
- The Street's average $SNYR price target is $3.75 (Strong Buy).
- $SNYR last traded around $0.20.
Ascendiant Capital reiterated its rating on Synergy CHC Corp. ($SNYR) to a "buy" rating, with a price target of $3.75 in a recent research note.
Synergy CHC Corp. ($SNYR) Stock
Synergy CHC Corp. Earnings
Analysts Set New Price Targets
About Synergy CHC Corp.
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.